[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-366344-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-366344-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","metal-based-nanomedicines-for-cancer-review-open-access","Metal-based nanomedicines for cancer - Review - open access","","Cancer cells’ heterogeneity and invasiveness create major obstacles for accurate diagnosis and effective therapy. Metal-based nanomedicines offer physicochemical features that interact with living organisms and trigger complex biological responses. These materials improve contrast and sensitivity in cancer imaging, helping distinguish cancerous from healthy tissues. They also support broad anticancer modalities including drug delivery, radiotherapy, photothermal and photodynamic therapy, sono-dynamic therapy, catalytic and ion interference approaches, and immunotherapy. A systematic overview covers mechanisms, synthesis/modification strategies, biosafety, latest imaging and treatment applications, plus clinical challenges and perspectives.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/metal-based-nanomedicines-for-cancer-review-open-access/366344/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/metal-based-nanomedicines-for-cancer-review-open-access/366344.png","ImageObject",300,407,{"name":42,"@type":43},"McQueen","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problems in cancer diagnosis and treatment does metal-based nanomedicines target?","Question",{"text":63,"@type":64},"They address challenges caused by the heterogeneity and invasiveness of cancer cells, and the difficulty of detecting subtle abnormalities before clear anatomical changes, as well as limitations of conventional therapies.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How are metal-based nanomedicines used in cancer imaging?",{"text":68,"@type":64},"They enhance contrast and sensitivity, supporting differentiation between cancerous and healthy tissues across multiple imaging modalities.",{"name":70,"@type":61,"acceptedAnswer":71},"What therapeutic approaches can metal-based nanomedicines support in cancer theranostics?",{"text":72,"@type":64},"They can be applied to drug delivery and various treatment strategies such as radiotherapy, photothermal therapy, photodynamic therapy, sono-dynamic therapy, catalytic therapy, ion interference therapy, and immunotherapy.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},366344,1790196730,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":97,"preview_urls":146},5909890329169,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Yu et al. Military Medical Research (2025) 12:41 [https://doi.org/10.1186/s40779-025-00627-x](https://doi.org/10.1186/s40779-025-00627-x)  \nREVIEW Open Access  \nMetal-based nanomedicines for cancer  \ntheranostics  \nHai‑Jia Yu1, Jian‑Hua Liu 1*, Wei Liu1, Rui Niu2,3, Bin Zhang2,4, Yuan Xiong5, Yang Liu6*, Ying‑Hui Wang2,4 and Hong‑Jie Zhang2,3,4*  \nAbstract  \nThe heterogeneity and invasiveness of cancer cells pose serious challenges in cancer diagnosis and treatment. Advancements and innovations in metal‑based nanomedicines provide novel avenues for addressing these chal‑ lenges. Metal‑based nanomedicines possess unique physicochemical properties that enable their interaction  \nwith living organisms, thereby inducing complex biological responses. These nanomaterials have been extensively used to enhance the contrast and sensitivity of cancer imaging and to amplify the distinction between cancerous and healthy tissues. Moreover, these nanomaterials can effectively combat a wide spectrum of cancers through vari‑ ous methods, including drug delivery, radiotherapy, photothermal therapy (PTT), photodynamic therapy (PDT), sono‑ dynamic therapy (SDT), biocatalytic therapy, ion interference therapy (IIT), and immunotherapy. Currently, there is still a need for a comprehensive summary on the metal‑based nanomaterials for cancer diagnosis and treatment. Herein, we present a systematic and complete overview of action mechanisms and the applications of metal‑based nanoma‑ terials in cancer theranostics. A summary of common strategies for synthesizing and modifying metal‑based nano‑ medicines is presented, and their biosafety is analyzed. Then, the latest developments in their applications for cancer imaging and anticancer treatment are provided. Finally, the key technical challenges and reasonable perspectives of metal‑based nanomedicines for cancer theranostics in clinical applications are discussed.  \nKeywords Metal‑based nanomedicines, Synthesis strategy, Computed tomography imaging, Nuclear imaging, Magnetic resonance imaging, Fluorescence imaging, Photoacoustic imaging, Drug‑delivery, Phototherapy, Catalytic therapy, Ion interference therapy, Immunotherapy  \n*Correspondence: Jian‑Hua Liu [jian_hua@jlu.edu.cn](jian_hua@jlu.edu.cn)[ ](jian_hua@jlu.edu.cn)Yang Liu [yang.l@ntu.edu.sg](yang.l@ntu.edu.sg)[ ](yang.l@ntu.edu.sg)Hong‑Jie Zhang [hongjie@ciac.ac.cn](hongjie@ciac.ac.cn)  \n1 Department of Radiology, The Second Hospital of Jilin University, Changchun 130041, China  \n2 State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China  \n3 Department of Chemistry, Tsinghua University, Beijing 100084, China  \n4 School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei 230026, China  \n5 Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China  \n6 School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, Singapore 637371, Singapore  \n© The Author(s) 2025, corrected publication 2025. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/","cbCaivTsFowVhLc6","https://ap.wps.com/l/cbCaivTsFowVhLc6","pdf",3419458,48,"English","# Abstract\n## Background\n## Challenges in current cancer diagnosis and treatment\n## Role and applications of metal-based nanomedicines\n## Summary scope and structure\n## Key strategies: synthesis, modification, biosafety\n## Latest imaging and anticancer applications\n## Clinical challenges and perspectives","[{\"question\":\"What problems in cancer diagnosis and treatment does metal-based nanomedicines target?\",\"answer\":\"They address challenges caused by the heterogeneity and invasiveness of cancer cells, and the difficulty of detecting subtle abnormalities before clear anatomical changes, as well as limitations of conventional therapies.\"},{\"question\":\"How are metal-based nanomedicines used in cancer imaging?\",\"answer\":\"They enhance contrast and sensitivity, supporting differentiation between cancerous and healthy tissues across multiple imaging modalities.\"},{\"question\":\"What therapeutic approaches can metal-based nanomedicines support in cancer theranostics?\",\"answer\":\"They can be applied to drug delivery and various treatment strategies such as radiotherapy, photothermal therapy, photodynamic therapy, sono-dynamic therapy, catalytic therapy, ion interference therapy, and immunotherapy.\"}]","Metal-based nanomedicines for cancer - Review - open access | PDF",1790164928,121,[147,151,155,159,163],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/41f13869eddc0a921c501f9ceb0242d8.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3e235023a87e6b5d11be554d227cfc40.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/32f2ba9abd17cd6e36cb4ff1ecabf24a.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1b97e597c1a012f47733059f65b724f4.webp",980,1301,{"page_no":97,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7ca73579bb89fb1cb98fb7b5a309dc94.webp",979,1300]